Zaibo Li, MD, PHD
Physician
Specialty:Pathology
Gender: Male
Academic Title: Professor in the College of Medicine
Research Program: Cancer Biology
Clinical Expertise
More info for- Pathology, Surgical
Research Interests
More info for- Papilloma
- Carcinoma, Squamous Cell
- Carcinoma
- Neoplasms
- Papillomavirus Infections
- Breast Neoplasms
- Adenocarcinoma
- Neoplasm Invasiveness
- Uterine Cervical Neoplasms
- Carcinoma in Situ
Education & Training
More info forMedical School
- Beijing Medical University
38 Xue Yuan Rd, Beijing 100083
Residency - Orthopaedic Surgery
- Peoples Liberation Army Hospital
4Th Ring Road, Beijing
Fellowship - Breast Pathology
- University of Pittsburgh Medical Center
200 Lothrop St, Pittsburgh, PA
Fellowship - Cytopathology
- University of Pittsburgh Medical Center
200 Lothrop St, Pittsburgh, PA
Residency - Pathology, Anatomic Pathology & Clinical Pathology
- University of Pittsburgh Medical Center
200 Lothrop St, Pittsburgh, PA
Graduate - Pathology - Anatomic
- University of Rochester School of Medicine/Dentistry
601 Elmwood Ave # 601, Rochester, NY
- Beijing Medical University
Academic Office & Contact Information
More info forAcademic Office:
Hamilton Hall
1645 Neil Ave
Columbus, Ohio 43210-1218Phone:
614-366-4859Email:
li.5765@osu.eduPublications
More info forDecember 1, 2024Computational pathology in the identification of HER2-low breast cancer: Opportunities and challenges.
Brevet M, Li Z, Parwani A
J Pathol Inform
September 4, 2024Identifying mesonephric-like adenocarcinoma of the endometrium by combining SOX17 and PAX8 immunohistochemistry.
Tahir M, Xing D, Ding Q, Wang Y, Singh K, Suarez AA, Parwani A, Li Z
Histopathology
August 31, 2024The RAL Small G Proteins Are Clinically Relevant Targets in Triple Negative Breast Cancer.
Han D, Spehar JM, Richardson DS, Leelananda S, Chakravarthy P, Grecco S, Reardon J, Stover DG, Bennett C, Sizemore GM, Li Z, Lindert S, Sizemore ST
Cancers (Basel)
July 8, 2024PP2A B55α Inhibits Epithelial-Mesenchymal Transition Via Regulation of Slug Expression in Non-Small Cell Lung Cancer.
Singh D, Qiu Z, Jonathan SM, Fa P, Thomas H, Chandra BP, Cai S, Wang JJ, Yan C, Zhang X, Venere M, Li Z, Sizemore ST, Wang QE, Zhang J
Cancer Lett
June 7, 2024Fumarate Hydratase-Deficient Abdominal Wall Leiomyoma Presenting a Decade Post-Fumarate Hydratase-Deficient Uterine Leiomyoma Excision: An Incidental or Syndromic Association?
Shaker N, Li Z, Shaker N, Poombal F, Sangueza OP, Pradhan D
Int J Surg Pathol
May 31, 2024The thioredoxin system determines CHK1 inhibitor sensitivity via redox-mediated regulation of ribonucleotide reductase activity.
Prasad CB, Oo A, Liu Y, Qiu Z, Zhong Y, Li N, Singh D, Xin X, Cho YJ, Li Z, Zhang X, Yan C, Zheng Q, Wang QE, Guo D, Kim B, Zhang J
Nat Commun
May 27, 2024Breast Cancer with HER2 IHC 2+ and Average HER2 Signals/Cell ≥ 6 and HER2/CEP17 Ratio < 2: A Multi-Institutional Cohort Analysis Emphasizing Outcome and Molecular Subtype.
Ajabnoor R, Zhang G, Hu Y, Gao Y, Finkelman BS, Turner BM, Yi S, Dhakal A, Audeh W, Li Z, Li X, Hicks DG, Zhang H
Mod Pathol
May 10, 2024Performance Analysis of Leica Biosystems Monoclonal Antibody Programmed Cell Death Ligand 1 Clone 73-10 on Breast, Colorectal, and Hepatocellular Carcinomas.
Shilo K, Shen T, Hammond S, Parwani AV, Li Z, Dayal S, Chiweshe J, Lian F
Appl Immunohistochem Mol Morphol
April 16, 2024The current state of digital cytology and artificial intelligence (AI): global survey results from the American Society of Cytopathology Digital Cytology Task Force.
Kim D, Thrall MJ, Michelow P, Schmitt FC, Vielh PR, Siddiqui MT, Sundling KE, Virk R, Alperstein S, Bui MM, Chen-Yost H, Donnelly AD, Lin O, Liu X, Madrigal E, Zakowski MF, Parwani AV, Jenkins E, Pantanowitz L, Li Z
J Am Soc Cytopathol
February 22, 2024Artificial intelligence's impact on breast cancer pathology: a literature review.
Soliman A, Li Z, Parwani AV
Diagn Pathol
February 10, 2024Automated imaging analysis of Ki-67 immunohistochemistry on whole slide images of cell blocks from pancreatic neuroendocrine neoplasms.
Shaker N, Shen R, Limbach AL, Satturwar S, Kobalka P, Ahmadian S, Sun S, Chen W, Lujan G, Esnakula A, Parwani A, Li Z
J Am Soc Cytopathol
January 9, 2024Cutaneous balloon-cell melanoma metastases to the axillary lymph node: Exploring cytomorphologic features and differential diagnoses on fine needle aspiration biopsy.
Shaker N, Li Z, Bamporiki J, Sangueza OP, Abid A
Cytopathology
December 12, 2023Cutaneous eccrine spiradenoma: Insights into cytomorphological features via fine needle aspiration biopsy and a comprehensive literature review.
Shaker N, Vohra P, Li Z, Sangueza OP, Abid A
Cytopathology
December 3, 2023Digital cytology part 1: digital cytology implementation for practice: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force.
Kim D, Sundling KE, Virk R, Thrall MJ, Alperstein S, Bui MM, Chen-Yost H, Donnelly AD, Lin O, Liu X, Madrigal E, Michelow P, Schmitt FC, Vielh PR, Zakowski MF, Parwani AV, Jenkins E, Siddiqui MT, Pantanowitz L, Li Z
J Am Soc Cytopathol
December 3, 2023Digital cytology part 2: artificial intelligence in cytology: a concept paper with review and recommendations from the American Society of Cytopathology Digital Cytology Task Force.
Kim D, Sundling KE, Virk R, Thrall MJ, Alperstein S, Bui MM, Chen-Yost H, Donnelly AD, Lin O, Liu X, Madrigal E, Michelow P, Schmitt FC, Vielh PR, Zakowski MF, Parwani AV, Jenkins E, Siddiqui MT, Pantanowitz L, Li Z
J Am Soc Cytopathol
October 13, 2023Comparing Accuracy of Helicobacter pylori Identification Using Traditional Hematoxylin and Eosin (H&E)-stained Glass Slides with Digital Whole Slide Imaging.
Chen W, Ziebell J, Arole V, Parkinson B, Yu L, Dai H, Frankel WL, Yearsley M, Esnakula A, Sun S, Gamble D, Vazzano J, Mishra M, Schoenfield L, Kneile J, Reuss S, Schumacher M, Satturwar S, Li Z, Parwani A, Lujan G
Lab Invest
October 2, 2023Comparison of four different displays for identification of select pathologic features extracted from whole slide images of surgical pathology cases.
Shaker N, Shilo K, Esnakula AK, Shafi S, Challa B, Patel A, Kellough DA, Hammond S, Javaid S, Satturwar S, Yearsley MM, Li Z, Limbach AL, Lujan G, Parwani AV
Pathol Res Pract
September 30, 2023Unlocking Translational Potential: Conditionally Reprogrammed Cells in Advancing Breast Cancer Research.
Daneshdoust D, Luo M, Li Z, Mo X, Alothman S, Kallakury B, Schlegel R, Zhang J, Guo D, Furth PA, Liu X, Li J
Cells
May 17, 2023SOX17 is a highly sensitive and specific marker for metastatic ovarian and endometrial carcinomas in cytology cell block specimens.
Satturwar S, Shaker N, Sinclair W, Shen R, Parwani AV, Ding Q, Li Z
Cancer Cytopathol
May 11, 2023Artificial Intelligence-Aided Diagnosis of Breast Cancer Lymph Node Metastasis on Histologic Slides in a Digital Workflow.
Challa B, Tahir M, Hu Y, Kellough D, Lujan G, Sun S, Parwani AV, Li Z
Mod Pathol
April 17, 2023Low-grade adenosquamous carcinoma of the breast: a clinical, morphological and immunohistochemical analysis of 25 patients.
Lewis G, Fong N, Gjeorgjievski SG, Li XB, Li Z, Wei S, Sturgis CD, Wang C, Komforti M, Zhang H, Downs E, Cui X, McIntire P, Hoda RS, Rowe JJ, Sciallis A, Zhang G
Histopathology
March 24, 2023Incidence, Clinicopathologic Features, HER2 FISH Profile and Oncotype DX Results of HER2-low Breast Cancers: Experience from a Single Academic Center.
Hu Y, Jones D, Zhao W, Tozbikian G, Wesolowski R, Parwani AV, Li Z
Mod Pathol
January 1, 2023Wnt Family Member 9b (Wnt9b) Is a Sensitive and Specific Marker for Triple-negative Breast Carcinoma Including Metaplastic Carcinoma.
Shaker N, Shafi S, Parkinson B, Chen W, Parwani AV, Ding Q, Li Z
Am J Surg Pathol
January 1, 2023HPV genotyping of cervical histologic specimens of 61, 422 patients from the largest women hospital in China.
Zhong F, Li Z, Sun Y, Xiao Y, Li J, Zhou X, Cong Q, Sui L, Tao X, Zhao C
Front Oncol
November 24, 2022New digital confocal laser microscopy may boost real-time evaluation of endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) from solid pancreatic lesions: Data from an international multicenter study.
Amendoeira I, Arcidiacono PG, Barizzi J, Capitanio A, Cuatrecasas M, Di Matteo FM, Doglioni C, Fukushima N, Fulciniti F, Ginès A, Giovannini M, Zaibo L, Lopes J, Lujan G, Parisi A, Poizat F, Reggiani Bonetti L, Stigliano S, Taffon C, Verri M, Crescenzi A
EBioMedicine
July 18, 2022Approach to Mediastinal Fine Needle Aspiration Cytology.
Li Z, Xu H, Fan F
Adv Anat Pathol
June 18, 2022Update on prognostic and predictive biomarkers of breast cancer.
Hou Y, Peng Y, Li Z
Semin Diagn Pathol
May 24, 2022PD-L1 (SP142 and 22C3) Immunohistochemistry in Clinical Metastatic Triple Negative or Low Hormone Receptor Breast Carcinomas: Experience from a Large Academic Institution.
Shafi S, Parwani AV, Li Z
Hum Pathol
April 14, 2022Immunohistochemical Markers for Distinguishing Metastatic Breast Carcinoma from Other Common Malignancies: Update and Revisit.
Ding Q, Huo L, Peng Y, Yoon EC, Li Z, Sahin AA
Semin Diagn Pathol
April 9, 2022TRPS1, GATA3, and SOX10 expression in triple-negative breast carcinoma.
Yoon EC, Wang G, Parkinson B, Huo L, Peng Y, Wang J, Salisbury T, Wu Y, Chen H, Albarracin CT, Resetkova E, Middleton LP, Krishnamurthy S, Gan Q, Sun H, Huang X, Shen T, Chen W, Parwani AV, Sahin AA, Li Z, Ding Q
Hum Pathol
March 4, 2022Avoiding "False Positive" and "False Negative" Immunohistochemical Results in Breast Pathology.
Li Z, Dabbs DJ
Pathobiology
March 1, 2022TRPS1 Expression in Breast Carcinomas: Focusing on Metaplastic Breast Carcinomas.
Parkinson B, Chen W, Shen T, Parwani AV, Li Z
Am J Surg Pathol
January 22, 2022Evaluating Mismatch Repair Status to Screen Clinical Advanced Breast Carcinomas for Immunotherapy: Experience From a Large Academic Institution.
Arole V, Shafi S, Challa B, Parwani AV, Tozbikian G, Li Z
Clin Breast Cancer
January 19, 2022Targeting squalene epoxidase interrupts homologous recombination via the ER stress response and promotes radiotherapy efficacy.
Hong Z, Liu T, Wan L, Fa P, Kumar P, Cao Y, Prasad CB, Qiu Z, Liu J, Wang H, Li Z, Wang QE, Guo P, Guo D, Yilmaz AS, Lu L, Papandreou I, Jacob NK, Yan C, Zhang X, She QB, Ma Z, Zhang J
Cancer Res
January 1, 2022Rules of engagement: Promoting academic-industry partnership in the era of digital pathology and artificial intelligence.
Pantanowitz L, Bui MM, Chauhan C, ElGabry E, Hassell L, Li Z, Parwani AV, Salama ME, Sebastian MM, Tulman D, Vepa S, Becich MJ
Acad Pathol
January 1, 2022Deep Learning-Based Pathology Image Analysis Enhances Magee Feature Correlation With Oncotype DX Breast Recurrence Score.
Li H, Wang J, Li Z, Dababneh M, Wang F, Zhao P, Smith GH, Teodoro G, Li M, Kong J, Li X
Front Med (Lausanne)
January 1, 2022Integrating and validating automated digital imaging analysis of estrogen receptor immunohistochemistry in a fully digital workflow for clinical use.
Shafi S, Kellough DA, Lujan G, Satturwar S, Parwani AV, Li Z
Adv Psychosom Med
August 17, 2021Diagnostic Challenges in Fine-Needle Aspiration Cytology of Mediastinal Tumors and Lesions.
Xu H, Fan F, Gong Y, Jing X, Lin X, Wang H, Lin F, Li Z
Arch Pathol Lab Med
July 23, 2021Prognostic value of androgen receptor expression and molecular alterations in metastatic triple negative or low hormone receptor breast carcinomas.
Shen T, Wei L, Li X, Parwani AV, Li Z
Hum Pathol
June 6, 2021Intraocular Metastases of Lung Origin: Case Reports and Cytology Correlates.
Amer HZM, Cebulla CM, Li Z, Shen R
Cytopathology
May 25, 2021M2 tumor-associated macrophages play important role in predicting response to neoadjuvant chemotherapy in triple-negative breast carcinoma.
Arole V, Nitta H, Wei L, Shen T, Parwani AV, Li Z
Breast Cancer Res Treat
May 14, 2021The reporting rates of high-grade squamous intraepithelial lesions and their human papillomavirus testing and histologic follow-up results: A comparison between ThinPrep and SurePath preparations.
Sinclair WD, Gibbons-Fideler IS, Shen R, Li Z
Diagn Cytopathol
March 17, 2021Quantitative Image Analysis for Tissue Biomarker Use: A White Paper From the Digital Pathology Association.
Lara H, Li Z, Abels E, Aeffner F, Bui MM, ElGabry EA, Kozlowski C, Montalto MC, Parwani AV, Zarella MD, Bowman D, Rimm D, Pantanowitz L
Appl Immunohistochem Mol Morphol
January 7, 2021A solitary brain metastasis as the only site of recurrence of HR positive, HER2 negative breast cancer: a case report and review of the literature.
Patel SH, Saito YD, Li Z, Ramaswamy B, Stiff A, Kassem M, Wesolowski R
J Med Case Rep
January 1, 2021Contemporary Whole Slide Imaging Devices and Their Applications within the Modern Pathology Department: A Selected Hardware Review.
Patel A, Balis UGJ, Cheng J, Li Z, Lujan G, McClintock DS, Pantanowitz L, Parwani A
Adv Psychosom Med
December 22, 2020Breast Fine-Needle Aspiration Practice in 2019: Results of a College of American Pathologists National Survey.
Li Z, Souers RJ, Tabbara SO, Natale KE, Nguyen LN, Booth CN
Arch Pathol Lab Med
October 26, 2020Interobserver agreement in programmed cell death-ligand 1 immunohistochemistry scoring in nonsmall cell lung carcinoma cytologic specimens.
Sinclair W, Kobalka P, Ren R, Beshai B, Lott Limbach AA, Wei L, Mei P, Li Z
Diagn Cytopathol
August 10, 2020HER2 immunohistochemistry staining positivity is strongly predictive of tumor response to neoadjuvant chemotherapy in HER2 positive breast cancer.
Zhao J, Krishnamurti U, Zhang C, Meisel J, Wei Z, Suo A, Aneja R, Li Z, Li X
Pathol Res Pract
July 13, 2020Magee Equations™ and response to neoadjuvant chemotherapy in ER+/HER2-negative breast cancer: a multi-institutional study.
Bhargava R, Esposito NN, O'Connor SM, Li Z, Turner BM, Moisini I, Ranade A, Harris RP, Miller DV, Li X, Moosavi H, Clark BZ, Brufsky AM, Dabbs DJ
Mod Pathol
July 1, 2020Features, Outcomes, and Management Strategies of Male Breast Cancer: A Single Institution Comparison to Well-Matched Female Controls.
Liu J, Suresh A, Palettas M, Stephens J, Ganju A, Morgan E, Kassem M, Hou Y, Parwani A, Noonan A, Reinbolt R, VanDeusen J, Sardesai S, Williams N, Cherian M, Tozbikian G, Stover DG, Lustberg M, Li Z, Ramaswamy B, Wesolowski R
Abstr Euro J of Hum Gen
June 10, 2020A genome-wide pooled shRNA screen identifies PPP2R2A as a predictive biomarker for the response to ATR and CHK1 inhibitors.
Qiu Z, Fa P, Liu T, Prasad CB, Ma S, Hong Z, Chan ER, Wang H, Li Z, He K, Wang QE, Williams TM, Yan C, Sizemore ST, Narla G, Zhang J
Cancer Res
June 7, 2020Review of Different Platforms to Perform Rapid Onsite Evaluation (ROSE) Via Telecytology.
Yao K, Li Z
Cytopathology
May 20, 2020Genetic Alterations and their Association with Clinicopathologic Characteristics in Advanced Breast Carcinomas: Focusing On Clinically Actionable Genetic Alterations.
Freitag CE, Mei P, Wei L, Parwani AV, Li Z
Hum Pathol
May 19, 2020Exploratory analysis of immune checkpoint receptor expression by circulating T cells and tumor specimens in patients receiving neo-adjuvant chemotherapy for operable breast cancer.
Wesolowski R, Stiff A, Quiroga D, McQuinn C, Li Z, Nitta H, Savardekar H, Benner B, Ramaswamy B, Lustberg M, Layman RM, Macrae E, Kassem M, Williams N, Sardesai S, VanDeusen J, Stover D, Cherian M, Mace TA, Yu L, Duggan M, Carson WE
BMC Cancer
May 11, 2020High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas.
Mei P, Freitag CE, Wei L, Zhang Y, Parwani AV, Li Z
Diagn Pathol
April 25, 2020HER2 intratumoral heterogeneity is independently associated with distal metastasis and overall survival in HER2-positive breast carcinomas.
Shen T, Nitta H, Wei L, Parwani AV, Li Z
Breast Cancer Res Treat
April 23, 2020Stromal platelet-derived growth factor receptor-β signaling promotes breast cancer metastasis in the brain.
Thies KA, Hammer AM, Hildreth BE, Steck SA, Spehar JM, Kladney RD, Geisler JM, Das M, Russell LO, Bey JF, Bolyard CM, Pilarski R, Trimboli AJ, Cuitiño MC, Koivisto CS, Stover DG, Schoenfield L, Otero J, Godbout J, Chakravarti A, Ringel MD, Ramaswamy B, Li Z, Kaur B, Leone G, Ostrowski MC, Sizemore ST, Sizemore GM
Cancer Res
Consulting and Related Relationships
More info forAt The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the university requires annual disclosures from all faculty members with external interests related to their university responsibilities. As of 09/30/2024, Dr. Li has reported relationships with the companies or entities listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office.
- Roche Diagnostics
- PathAI
- AIxMed Inc.
- Guangzhou Trials Medical Technology Co. Ltd.